You are here
-
Biotin-beta-Amyloid (1-42)
Description Aß (1-42), a major component of amyloid plaques, accumulates in neurons of Alzheimer’s disease brains. Biochemical analysis of the amyloid peptides isolated from Alzheimer’s disease brain indicates that Aß (1-42) is the principal species associated with senile plaque amyloids, while Aß (1-40) is more abundant in cerebrovascular amyloid deposit. This peptide is biotinylated at the N-terminus. (Shipping Cost: €35.00) 
0 mg more info 
3 days 
€96,00 Add to cart -
Beta-Amyloid (1-40)-Lys(Biotin-LC)
Description This C-terminal biotinylated Aß(1-40) contains a 6-carbon long chain (LC) to provide more accesibility for avidin attachment. (Shipping Cost: €35.00)
0 mg more info 3 days
€179,00 Add to cart -
Biotin-LC-beta-Amyloid (1-42)
Description This biotinylated Aß(1-42) contains an 6-carbon long chain (LC) to provide more accessibility for avidin attachment. (Shipping Cost: €35.00)
0 mg more info 3 days
€163,00 Add to cart -
Beta-Amyloid (1-42), sodium salt
Description Aß (1-42), a major component of amyloid plaques, accumulates in neurons of Alzheimer’s disease brains. Biochemical analysis of the amyloid peptides isolated from Alzheimer’s disease brain indicates that Aß (1-42) is the principal species associated with senile plaque amyloids, while Aß (1-40) is more abundant in cerebrovascular amyloid deposit. This peptide prepared by neutralizing the TFA salt form of Aß (1-42) with a diluted sodium hydroxide solution has superior solubility and fibrillogenesis properties, and the fibrils are equally neurotoxic. (Shipping Cost: €35.00)
0 mg more info 3 days
€112,00 Add to cart -
Biotin-beta-Amyloid (1-40)
Description Aß (1-40) together with Aß (1-42) are two major C-terminal variants of the Aß protein constituting the majority of Aßs. These undergo post-secretory aggregation and deposition in the Alzheimer’s disease brain. This peptide is biotinylated at its N-terminus (Shipping Cost: €35.00)
0 mg more info 3 days
€112,00 Add to cart -
[Pyr3]-beta-Amyloid (3-40)
Description A hallmark of Alzheimer's disease (AD) is the presence of beta-Amyloid in plaques in the brains of patients. N-terminally truncated pyroglutamate-modified beta-Amyloid forms such as Aß(3-40) and Aß (11- 40) have been described as major compounds in the senile plaques. Pyro-Glu modified beta-Amyloid forms are more resistant to degradation, show higher toxicity and have increased aggregation propensity compared to non-modified beta-Amyloid. (Shipping Cost: €35.00)
0 mg more info 3 days
€77,00 Add to cart -
Beta-Amyloid (1-42), FAM-labeled
Description Aß (1-42), a major component of amyloid plaques, accumulates in neurons of Alzheimer’s disease brains. Biochemical analysis of the amyloid peptides isolated from Alzheimer’s disease brain indicates that Aß (1-42) is the principal species associated with senile plaque amyloids, while Aß (1-40) is more abundant in cerebrovascular amyloid deposit. This is a fluorescent (FAM)-labeled ß-Amyloid peptide, Abs/Em=494/521 nm. (Shipping Cost: €35.00)
0 mg more info 3 days
€168,00 Add to cart -
Beta-Amyloid (2-42)
Description This peptide is beta-amyloid (1-42) N-terminally truncated. It was shown that supplementing the media with N-terminally truncated Abeta (2-40) and (2-42) induce the phagocytosis of polystyrene particles by primary human monocytes. N-terminally truncated Aβ(x–42) induced the phagocytosis of PSPs significantly more effectively than did Aβ(x–40). (Shipping Cost: €35.00)
0 mg more info 3 days
€93,00 Add to cart -
Beta-Amyloid (3-42)
Description This peptide is beta-amyloid (1-42) N-terminally truncated. It is the non-pyroglatamate form of beta-Amyloid (3-42). N-terminally truncated pyroglutamate-modified beta-Amyloid forms such as Aß(3-42) and Aß (11- 42) have been described as major compounds in the senile plaques. Pyro-Glu modified beta-Amyloid forms are more resistant to degradation, show higher toxicity and have increased aggregation propensity compared to non-modified beta-Amyloid. | Pyroglutamyl (pGlu) peptides may spontaneously form when either Glutamine (Q) or Glutamic acid (E) is located at the sequence N-terminus. The conversion of Q or E to pGlu is a natural occurrence and in general it is believed that the hydrophobic γ-lactam ring of pGlu may play a role in peptide stability against gastrointestinal proteases. Pyroglutamyl peptides are therefore considered a normal subset of such peptides and are included as part of the peptide purity during HPLC analysis. (Shipping Cost: €35.00)
0 mg more info 3 days
€93,00 Add to cart -
[Gla17,21,24]-Osteocalcin (1-49)
Description Osteocalcin (OC) is a 49 amino acid peptide found exclusively in bone tissue and is highly conserved among species. It is a vitamin K- and D-dependent protein produced by osteoblasts, osteocytes and odontoblasts. It is deposited in extracellular bone matrix and is found in the serum. Serum osteocalcin, hydrolysed in the kidney and liver, is considered a specific marker of osteoblast activity and bone formation rate. It may be involved in regulation of osteoblast function, regulation of bone turnover and/or mineralization. (Shipping Cost: €35.00)
0 mg more info 3 days
€127,00 Add to cart
